Drug Device Combination Products Market is estimated to be US$ 277.9 billion by 2030 with a CAGR of 7.8% during the forecast period

 




Drug device combination product is a product composed of any combination of a drug and a device which is a biological product and a device. Drug device combination product is composed of two or more regulated components which are physically, chemically, or otherwise combined or mixed and produced as single entity. For instance, monoclonal antibody combined with a therapeutic drug and device coated or impregnated with a drug or biologic. The Global Drug Device Combination Product Market accounted for US$ 130.4 billion in 2020 and is estimated to be US$ 277.9 billion by 2030 and is anticipated to register a CAGR of 7.8%.

 

The report " Drug Device Combination Products Market, By Product (Infusion Pumps (Volumetric, Disposables, Syringes, Ambulatory, Implantable, and Insulin), Orthopedic Combination Products (Bone Graft Implants and Antibiotic Bone Cement), Photodynamic Therapy Devices, Transdermal Patches, Drug Eluting Stents (Coronary Stents and Peripheral Vascular Stents), Wound Care Products, Inhalers (Dry Powder, Nebulizers, and Metered Dose), Antimicrobial Catheters (Urological, Cardiovascular, and Others), and Others. By Wound Type (Cardiovascular Disease, Diabetes, Respiratory Problem, Cancer Treatment, Antimicrobial Application, and Other Applications (Neurological, Skin Treatments, Etc.)), By End-User (Hospital and Clinic, Ambulatory Surgery Center (ASC), and Home Care Setting), and Region - Global Forecast to 2030" 

 

Drug Device Combination Product Market accounted for US$ 130.4 billion in 2020 and is estimated to be US$ 277.9 billion by 2030 and is anticipated to register a CAGR of 7.8%. Physician and patients gives preference for minimally invasive procedures and consistent-dosing treatment alternatives drives the global drug device combination products market. Further, rising incidences of chronic diseases such as hyper tension, obesity, cancer, and diabetes is expected to boost the global drug device combination products market.

Key Highlights:

·         On 12 April 2019, Cipla Limited launched “Niveoli” inhaler, is a new product combination formulations and drug-device combinations in the respiratory therapy.

Key Market Insights from the report:          

The Global Drug Device Combination Product Market accounted for US$ 130.4 billion in 2020 and is estimated to be US$ 277.9 billion by 2030 and is anticipated to register a CAGR of 7.8%. The market report has been segmented on the basis of product, wound type, end-user, and region.

·         By product, the transdermal patch segment is accounted for major share in the global drug device combination products market. This can be attributed to rising demand for self-administration of drugs in cases of diseases requiring long-term treatment.

·         By wound type, the global drug device combination products market is segmented into cardiovascular disease, diabetes, respiratory problem, cancer treatment, antimicrobial application, and other. Others sub-segment is divided into neurological, skin treatments, etc.

·         By end-user, the global drug device combination products market has been segmented into hospital and clinic, ambulatory surgery center (ASC), and home care setting.

·         By region, North America drug device combination products market is expected to account for major share in terms of revenue in the global drug device combination products market over the forecast period. This can be attributed to increasing prevalence of chronic diseases, coupled with prominent players pour their efforts for launching new product in countries of the region. Asia Pacific drug device combination products market is expected to account for significant share in terms of revenue in the target market in the near future.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2230    

The prominent player operating in the global drug device combination products market include Abbott Laboratories, Terumo Corporation, Stryker Corporation, Mylan N.V., Medtronic plc, Allergan plc, Boston Scientific Corporation, Novartis AG, Becton Dickinson, and Cipla Limited. 

 

About Prophecy Market Insights

Prophecy Market Insights is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

 

Comments

Post a Comment

Popular posts from this blog

Patient Portal Market is estimated to be US$ 7862.01 billion by 2030 with a CAGR of 11.50% during the forecast period

Image
  Patient Portal Market  accounted for US$ 2643.21 million in 2020 and is estimated to be US$ 7862.01 million by 2030 and is anticipated to register a CAGR of 11.50%. The patients can share and view their health information and communicate remotely. These characteristics enables patients to look into various data points, such as diagnostic test results, medical history, and prescription information. Patient portal is one of the many tools that allow the healthcare payers and providers to arrive at outcomes, which are patient-centric. Rapid technological advancements in the digital space are rising the engagement level of patients in the entire healthcare ecosystem. Data points collected on a per-patient basis through patient portal can be used for performing pin-point diagnosis, designing better clinical trials, and helping in the elimination of administration of redundant therapies and drugs to individual patients. The report   "   Global Patient Portal Market, By P...
Read more

Knee Replacement Market is estimated to be 14.2 billion by 2029 with a CAGR of 4.3% during the forecasted period.

Image
  knee replacement market  accounted for 9.7 billion in 2020 and is estimated to be US$ 14.2 billion by 2029 and is anticipated to register a CAGR of 4.3%. The report " Global Knee Replacement Market, By Product ( Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Complex (or revision) Knee Replacement),  By End Users ( Hospitals, Orthopedic Centers, and Other ),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2018, Smith and Nephew announced commercial release of bi-cruciate retaining Journey II XR total knee arthroplasty across the U.S. and Japan. The product launch was aimed at capturing large customer base with innovative product offering. In October 2018, Zimmer Biomet Holdings announced to collaborate with Apple to facilitate patient and surgeon connection during the knee and hip replacement procedures. Th...
Read more

Nuclear Medicine Market is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period

Image
  The Nuclear Medicine Market accounted for US$ 4.26 billion and is estimated to be US$ 6.49 billion by 2030 with a CAGR of 4.30% during the forecast period. Nuclear medicine may be a medicine involving the appliance of radioactive substances within the diagnosis and treatment of disease. Medicine imaging, during a sense, is "radiology done inside out" or "endoradiology" because it records radiation emitting from within the body instead of radiation that's generated by external sources like X-rays. Additionally, medicine scans differ from radiology, because the emphasis isn't on imaging anatomy, but on the function. For such reason, it's called a physiological imaging modality. Single photon emission computerized tomography (SPECT) and positron emission tomography (PET) scans are the 2 commonest imaging modalities in medicine.   The report "  Global Nuclear Medicine Market, By Diagnostics (Single Photon Emission, Computed Tomography (SPECT), an...
Read more